EGFR kinase inhibitor and preparation method and use thereof
US10710979B2 · kind B2 · utility
0Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2016 |
| Grant date | Jul 14, 2020 |
| Priority date | — |
| Expiry date | Jul 21, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an EGFR kinase inhibitor and a preparation method and use thereof. Specifically, the present invention provides a compound as shown in formula (I), the definition of each group therein being as described in the description. Said compound is an efficient EGFR inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.